Insmed Inc (INSM)
24.92
-0.89
(-3.45%)
USD |
NASDAQ |
Apr 25, 16:00
24.91
-0.01
(-0.04%)
After-Hours: 20:00
Insmed Cash from Investing (TTM): -223.60M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -223.60M |
September 30, 2023 | -205.10M |
June 30, 2023 | -162.83M |
March 31, 2023 | 108.42M |
December 31, 2022 | -34.58M |
September 30, 2022 | -106.11M |
June 30, 2022 | -163.93M |
March 31, 2022 | -164.51M |
December 31, 2021 | -64.28M |
September 30, 2021 | -14.58M |
June 30, 2021 | -6.928M |
March 31, 2021 | -5.324M |
December 31, 2020 | -6.822M |
September 30, 2020 | -18.34M |
June 30, 2020 | -32.19M |
March 31, 2020 | -40.92M |
December 31, 2019 | -42.27M |
September 30, 2019 | -33.98M |
June 30, 2019 | -21.24M |
March 31, 2019 | -13.48M |
December 31, 2018 | -14.81M |
September 30, 2018 | -11.76M |
June 30, 2018 | -10.36M |
March 31, 2018 | -7.949M |
December 31, 2017 | -3.001M |
Date | Value |
---|---|
September 30, 2017 | -2.073M |
June 30, 2017 | -2.926M |
March 31, 2017 | -4.029M |
December 31, 2016 | -4.20M |
September 30, 2016 | -3.835M |
June 30, 2016 | -3.388M |
March 31, 2016 | -2.778M |
December 31, 2015 | -3.454M |
September 30, 2015 | -4.574M |
June 30, 2015 | -6.64M |
March 31, 2015 | -6.274M |
December 31, 2014 | -5.341M |
September 30, 2014 | -3.927M |
June 30, 2014 | 0.925M |
March 31, 2014 | 1.159M |
December 31, 2013 | 1.329M |
September 30, 2013 | 46.03M |
June 30, 2013 | 44.07M |
March 31, 2013 | 48.52M |
December 31, 2012 | 61.52M |
September 30, 2012 | 27.42M |
June 30, 2012 | 36.08M |
March 31, 2012 | 30.71M |
December 31, 2011 | 34.36M |
September 30, 2011 | 33.85M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-223.60M
Minimum
Dec 2023
108.42M
Maximum
Mar 2023
-65.22M
Average
-34.58M
Median
Dec 2022
Cash from Investing (TTM) Benchmarks
NeuroMetrix Inc | 1.156M |
Intra-Cellular Therapies Inc | 105.54M |
Rhythm Pharmaceuticals Inc | -5.665M |
Amylyx Pharmaceuticals Inc | 92.05M |
AN2 Therapeutics Inc | -43.28M |